Hemagglutinin (HA) (Influenza A virus subtype H5N8) (HA)

Hemagglutinin (HA) is the primary surface glycoprotein of the Influenza A virus subtype H5N8 and is the essential mediator of viral entry into host cells (UniProt, 2023). It functions by binding to sialic acid receptors on the host cell surface, facilitating receptor-mediated endocytosis (CDC, 2022). Once inside the endosome, the acidic environment triggers a dramatic conformational change in the HA protein, leading to the fusion of the viral and endosomal membranes (Skehel & Wiley, 2000). In the context of the immune system, HA is the dominant antigen targeted by the host's adaptive response; the recognition of HA by B cells leads to the production of neutralizing antibodies that can prevent infection (WHO, 2021). Vaccines against H5N8 primarily utilize the HA protein to induce protective immunity, while therapeutic monoclonal antibodies often target conserved regions of the HA stem to provide broad-spectrum protection (PubMed, 2023). Due to the high pathogenicity of H5N8 in poultry and its potential for zoonotic transmission, HA remains a critical target for global surveillance and pandemic preparedness efforts (CDC, 2022). The protein is composed of two subunits, HA1 and HA2, which are generated by the cleavage of a precursor protein, a process vital for viral infectivity (Skehel & Wiley, 2000). Antigenic drift in the HA head region allows the virus to evade existing immunity, necessitating the continuous monitoring of circulating strains (WHO, 2021).

Other names

H5 HemagglutininHA proteinSurface glycoproteinH5N8 HAInfluenza A H5N8 viral antigens

Neutralizing antibodies and fusion inhibitors bind to the hemagglutinin protein to block its ability to bind to host cell sialic acid receptors or to prevent the conformational change required for membrane fusion (Skehel & Wiley, 2000; WHO, 2021).